Total raised
$592.9M
Last: 2024-06
Stage
Series G
Founded
1999
Headcount
499
HQ
Tirat Carmel
Sector
Health Tech & Life Sciences
About
INSIGHTEC is a global healthcare company creating the next generation of patient care by realizing the therapeutic power of acoustic energy. The company's Exablate Neuro platform focuses sound waves, safely guided by MRI, to provide tremor treatment to patients with medication-refractory Essential Tremor and Parkinson's Disease.
INSIGHTEC obtained FDA approval for its technology in 2016 and 2018. Also received FDA approval and CE Mark of its Exablate Prime system. It is continuously investing in and expanding its current and investigational applications, ranging from functional neurosurgery to oncology and gynecology.
Funding history · 9 rounds · $592.9M total
2024-06
Undisclosed Round
$150.0M
2022-09
Debt Financing
$200.0M
2021-04
Series F
$136.0M
2017-12
Series E
$150.0M
2016-01
Series D
$22.0M
2014-12
Series D
$59.0M
2012-12
Series C
$30.9M
2007-11
Series A
$30.0M
2006-09
Undisclosed
$15.0M
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Simulation & ImagingUltrasoundPlatforms & InterfacesSoftware
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Highlights
1 Patents
Tags
monitoringmedical-devicesoncologyhospitalsnon-invasivegynecologycancerunicorn-2020urologyneurologywomen-healthultrasoundparkinsonneurosurgeryhardwaresoftware-applicationsbonetreatments